About BioPlx
BioPlx is a company based in Kanpur (India) founded in 2016 by Ravi Starzl. It operates as a B2B. BioPlx has raised $2.72 million across 2 funding rounds. BioPlx operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
- Headquarter Kanpur, India
- Founders Ravi Starzl
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Bioplx Microbiomics Pvt. Ltd.
- Date of Incorporation 01 Sep, 2016
- Jurisdiction Meerut, Uttar Pradesh, India
-
Annual Revenue
Not available
-
Net Profit
-$7.26 K (USD)74.44as on Mar 31, 2023
-
EBITDA
-$6.43 K (USD)76.36as on Mar 31, 2023
-
Total Equity Funding
$2.72 M (USD)
in 2 rounds
-
Latest Funding Round
$1.08 M (USD), Seed
Feb 24, 2020
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of BioPlx
BioPlx has successfully raised a total of $2.72M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.08 million completed in February 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by BioPlx
Investment portfolio details for BioPlx
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BioPlx
Detailed financials for BioPlx
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bioplx Comparisons
Peer comparison for BioPlx
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BioPlx
BioPlx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
Dental implants and regenerative dentistry products are developed.
|
|
| Locked | Locked | Locked |
RNA-editing technologies are provided for precision medicine applications.
|
Detailed competitors of BioPlx
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bioplx
Complete news archive for BioPlx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioPlx
BioPlx was founded in 2016 and raised its 1st funding round 3 years after it was founded.
BioPlx is headquartered in Kanpur, India. It is registered at Kanpur, Uttar Pradesh, India.
Ravi Starzl is the current CEO of BioPlx. They have also founded this company.
BioPlx is a funded company, having raised a total of $2.72M across 2 funding rounds to date.
BioPlx, established in 2016 and currently in Dissolved stage, focuses on providing healthcare solutions, advancing biotech innovations, infectious disease control, and non-antibiotic methods. Delivers comprehensive non-antibiotic solutions for infectious disease control. Adapting to market demands with innovation and client-focused strategies.
BioPlx's top competitors include Sutro Biopharma, Avidity Biosciences and Antheia.